{"lastClose": 6.019999980926514, "len": 1104, "date": "2023-03-02", "alpha_1": -0.22173888571455092, "beta_1": 1.6570702864721238, "drawup_1": 1.5486725887776869, "natr_1": 14.462859812651324, "sup_1": -0.5127353673896978, "res_1": 0.3765227138582319, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 43.42291331927911, "adx_1": 8.421997693443515, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.12447699801739769, "stratHoldAlpha_1": 250.9127681000418, "stratHoldDrawdown_1": -0.6387485724635547, "alpha_3mo": -0.2742336793767892, "beta_3mo": 2.0104565285597973, "drawup_3mo": 0.4608541290620036, "natr_3mo": 14.462859812651324, "sup_3mo": -0.06035430373919811, "res_3mo": 0.05204878260648, "bullPattern_3mo": [], "bearPattern_3mo": ["HIKKAKE"], "rsi_3mo": 31.557368319122993, "adx_3mo": 42.115094426964085, "drawdown_3mo": -0.4008528979752518, "stratHoldSharpe_3mo": -2.4044308624500585, "stratHoldAlpha_3mo": 249.5263078461496, "stratHoldDrawdown_3mo": -0.3607676081777267, "Market Cap": 873192482, "Country": "United States", "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "alpha%_1": 0.30289007829880255, "beta%_1": 0.9095291890022992, "drawup%_1": 0.9973151447887931, "natr%_1": 0.9999971612178027, "drawdown%_1": 0.06313480971080765, "stratHoldSharpe%_1": 0.3822786775602036, "stratHoldAlpha%_1": 0.3227511529231175, "stratHoldDrawdown%_1": 0.049083153598802415, "alpha%_3mo": 0.17439976080511077, "beta%_3mo": 0.958181018839079, "drawup%_3mo": 0.8849763823036487, "natr%_3mo": 0.9999957848646033, "drawdown%_3mo": 0.0012976958977578494, "stratHoldSharpe%_3mo": 0.038390922471946545, "stratHoldAlpha%_3mo": 0.0012409044609064661, "stratHoldDrawdown%_3mo": 0.0015213298464007614}